CPIX earnings date and last-quarter result: last quarter beat, P/E -14.39. Updated 2026-07-23.
Cumberland Pharmaceuticals (CPIX) Research Hub
Cumberland Pharmaceuticals (CPIX) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 4.35 USD (-48.76%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -14.39, market cap 0.11B. This hub links to the full technical, earnings and options research available for CPIX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.35 USD (-48.76%) |
| 52-week range | 4.31 USD – 9.28 USD |
| Trend regime | Range |
| 14-day RSI | 32 (Bearish) |
| Trailing P/E | -14.39 |
| Market cap | 0.11B |
| Dividend yield | 0.00% |
Available research for CPIX
Covered Call on CPIX: how it works, illustrative setup around the real 4.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CPIX: how it works, illustrative setup around the real 4.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CPIX: how it works, illustrative setup around the real 4.35 USD price, max profit/loss, breakeven and when to use it. Educational.
CPIX technical analysis: range, last 4.35 USD, RSI 32, 52w range 4.31 USD–9.28 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CPIX in?
Cumberland Pharmaceuticals (CPIX) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.
Is CPIX in an uptrend or downtrend?
As of 2026-10-26, CPIX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CPIX's trailing P/E ratio?
CPIX's trailing P/E is -14.39, with a market cap of 0.11B. See the earnings research page for full valuation detail.